NDC 54925-032 - TRI OTIC
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54925-032
- Package NDCs from labels
- 54925-032-75, 54925-032-15, 54925-032-10, 54925-032-45, 54925-032-25, 54925-032-40
- Manufacturer
- Med-Pharmex, Inc
- Effective date
- 2023-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TRI OTIC - Med-Pharmex, Inc | Med-Pharmex, Inc | 2023-07-14 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BETAMETHASONE VALERATE | ACTIVE INGREDIENT | 9IFA5XM7R2 | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| CLOTRIMAZOLE | ACTIVE INGREDIENT | G07GZ97H65 | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| BETAMETHASONE | ACTIVE MOIETY | 9842X06Q6M | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| CLOTRIMAZOLE | ACTIVE MOIETY | G07GZ97H65 | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | TRI OTIC (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE ) OINTMENT [MED-PHARMEX, INC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | NuCare Pharmaceuticals,Inc. | 64badc1a-8922-c6e3-e053-2991aa0a8b1c | 2024-06-06 | Adverse reactions | 9IFA5XM7R2 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | NuCare Pharmaceuticals,Inc. | 5cc511e4-3e7d-70d6-e053-2a91aa0a8044 | 2024-06-04 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Cardinal Health 110 dba LEADER | 199df107-3384-6e03-e063-6294a90afc38 | 2024-05-29 | Warnings | G07GZ97H65 |
| Femmesil | CLOTRIMAZOLE | Aidance Skincare & Topical Solutions, LLC | efddad82-9dc7-4cd9-b33c-7e85f30d992e | 2024-05-24 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | QUALITY CHOICE (Chain Drug Marketing Association) | 3c676ff0-44a8-40cd-8f85-d39dda3d9637 | 2024-05-23 | Warnings | G07GZ97H65 |
| Up and Up Athletes Foot | CLOTRIMAZOLE 1% | Target Corporation | 52b61859-11ae-4990-aa0c-9dc1dd00adf4 | 2024-05-08 | Warnings | G07GZ97H65 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Padagis Israel Pharmaceuticals Ltd | dc5dfd3e-7762-40c8-880e-c7db80d87749 | 2024-03-31 | Warnings, Adverse reactions | 9IFA5XM7R2 |
| Clotrimazole Antifungal | CLOTRIMAZOLE | Trifecta Pharmaceuticals USA, LLC. | 11bf50db-552e-0a39-e063-6394a90af60d | 2024-02-19 | Warnings | G07GZ97H65 |
| GENTAMICIN | GENTAMICIN | HF Acquisition Co LLC, DBA HealthFirst | c1ff0cdc-ac5d-30ca-e053-2a95a90a5066 | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | HF Acquisition Co LLC, DBA HealthFirst | e9fbe619-2afe-f1d7-e053-2a95a90aab29 | 2024-01-27 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Target Jock Itch | CLOTRIMAZOLE 1% | Target Corporation | f44d4c44-99d1-413f-b9c3-8330bdd21abb | 2024-01-17 | Warnings | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | a9486ae1-350b-41c5-ae0c-a4d692bb2dfd | 2024-01-15 | Adverse reactions | 8X7386QRLV |
| gentamicin sulfate | GENTAMICIN SULFATE | DIRECT RX | 51a411a0-2671-4c1c-bf25-e29b32efed0c | 2024-01-10 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Sandoz Inc | a213fb9c-08ea-4f30-a6c9-93c7a9ba5280 | 2024-01-02 | Warnings, Adverse reactions | 8X7386QRLV |
| clotrimazole | CLOTRIMAZOLE | Proficient Rx LP | eeb241a3-93ee-4b74-8cbb-65713d15e7e0 | 2024-01-01 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Proficient Rx LP | ba1dc4a4-073f-4f30-bb9c-9ed043700431 | 2024-01-01 | Warnings | G07GZ97H65 |
| RUGBY ANTIFUNGAL CLOTRIMAZOLE | CLOTRIMAZOLE | Proficient Rx LP | 7c64553b-589c-4e65-a6f0-b2847bbbe8a6 | 2024-01-01 | Warnings | G07GZ97H65 |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | 8bdeef7f-ad8e-46e0-a872-e945eae51d68 | 2023-12-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE | A-S Medication Solutions | f8711d17-de6a-45e3-8027-b650308207ed | 2023-12-15 | Adverse reactions | 9IFA5XM7R2 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | A-S Medication Solutions | d265d143-343f-41ec-9cb4-18d83edb772b | 2023-12-12 | Adverse reactions | 9IFA5XM7R2 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.